Principal Investigator
Sangeetha Venugopal
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230816
Clinical Trial Summary
A Phase 1 Study of M3814 in combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Phase
Phase I
Funding Agency/Sponsor
National Cooperative Group
Disease
Leukemia
Contact Information
Phone Number
+1 (305) 2437261